The FDAs new indication for semaglutide (Wegovy, Novo Nordisk) comes a little more than 18 months after the medication was initially approved in June 2021 for chronic weight management in adults with obesity or with overweight plus one weight-related condition
You may feel a small pinch when the needle is placed, but discomfort is usually minimal and brief
This includes selecting the correct injection sitesuch as the abdomen, thigh, or upper armand rotating sites to avoid irritation
While giving yourself an injection for the first time may seem intimidating, the process is straightforward and usually takes only a few minutes
Research is ongoing to find the exact cause
One 72-week trial with a 20-week escalation found these results: 5 milligrams weekly: 15% weight reduction 10 milligrams weekly: 19.5% weight reduction 15 milligrams weekly: 20.9% weight reduction Further tirzepatide trials have been completed and show that with low-calorie diets and regular exercise, tirzepatide users can expect a total weight reduction of up to 26%